ADSS1
Basic information
Region (hg38): 14:104724174-104747325
Previous symbols: [ "ADSSL1" ]
Links
Phenotypes
GenCC
Source:
- myopathy, distal, 5 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Myopathy, distal, 5 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 26506222; 28268051; 32331917; 32646962 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (366 variants)
- Inborn_genetic_diseases (117 variants)
- Myopathy,_distal,_5 (32 variants)
- ADSS1-related_disorder (20 variants)
- not_specified (5 variants)
- Fetal_akinesia_deformation_sequence_1 (1 variants)
- Arthrogryposis_multiplex_congenita (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADSS1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000152328.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 80 | 84 | ||||
missense | 175 | 183 | ||||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 12 | |||||
splice donor/acceptor (+/-2bp) | 12 | |||||
Total | 12 | 14 | 181 | 83 | 6 |
Highest pathogenic variant AF is 0.000180386
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADSS1 | protein_coding | protein_coding | ENST00000332972 | 13 | 23140 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.82e-7 | 0.982 | 125578 | 2 | 168 | 125748 | 0.000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0328 | 306 | 304 | 1.01 | 0.0000184 | 3206 |
Missense in Polyphen | 148 | 139.96 | 1.0574 | 1315 | ||
Synonymous | 0.811 | 117 | 129 | 0.909 | 0.00000874 | 1007 |
Loss of Function | 2.20 | 15 | 27.4 | 0.547 | 0.00000145 | 294 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00205 | 0.00205 |
Ashkenazi Jewish | 0.000994 | 0.000993 |
East Asian | 0.00131 | 0.00131 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.000469 | 0.000457 |
Middle Eastern | 0.00131 | 0.00131 |
South Asian | 0.000557 | 0.000523 |
Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the purine nucleotide cycle (PNC), which interconverts IMP and AMP to regulate the nucleotide levels in various tissues, and which contributes to glycolysis and ammoniagenesis. Catalyzes the first committed step in the biosynthesis of AMP from IMP. {ECO:0000269|PubMed:26506222}.;
- Pathway
- Alanine, aspartate and glutamate metabolism - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Hypoacetylaspartia;Aspartate Metabolism;Canavan Disease;adenosine ribonucleotides <i>de novo</i> biosynthesis;Metabolism of nucleotides;Alanine Aspartate Asparagine metabolism;Metabolism;Nucleobase biosynthesis;Purine nucleotides nucleosides metabolism;superpathway of purine nucleotide salvage;Purine ribonucleoside monophosphate biosynthesis;purine nucleotides <i>de novo</i> biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.155
Intolerance Scores
- loftool
- 0.875
- rvis_EVS
- -0.02
- rvis_percentile_EVS
- 52.25
Haploinsufficiency Scores
- pHI
- 0.257
- hipred
- Y
- hipred_score
- 0.542
- ghis
- 0.610
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.683
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Adssl1
- Phenotype
Zebrafish Information Network
- Gene name
- adssl1
- Affected structure
- skeletal muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- apoptotic
Gene ontology
- Biological process
- immune system process;AMP biosynthetic process;aspartate metabolic process;glutamine metabolic process;purine ribonucleoside monophosphate biosynthetic process;response to muscle activity;cellular response to drug;response to starvation;'de novo' AMP biosynthetic process;IMP metabolic process;cellular response to electrical stimulus
- Cellular component
- cytoplasm;cytosol
- Molecular function
- magnesium ion binding;GTPase activity;adenylosuccinate synthase activity;GTP binding;phosphate ion binding;protein homodimerization activity;actin filament binding